Advance care planning (ACP) with people with dementia and their caregivers: development of an ACP communication in dementia skills training for physicians Vrije Universiteit Brussel
Monoaminergic and neuroinflammatory markers in dementia with Lewy bodies to improve differential dementia diagnosis. University of Antwerp
Characterization and validation of biological markers of dementia and mild cognitive impairment University of Antwerp
Unraveling the link between depression and dementia Vrije Universiteit Brussel
The amount of patients and care providers confronted with these
illnesses is expected to rise significantly due to aging populations, posing a significant individual and societal burden. Current research suggests depression may be a risk factor for the development of dementia in some people, as well as that it may be the first symptom of dementia in others, while possibly ...
Re-membering "strange compositions": a visual anthropological inquiry with Flemish elderly with dementia into inclusive trajectories and rhizomatic narrativity. KU Leuven
There is a space for people with dementia in contemporary society. Their personhood in despite of the disease is recognized, the quality of care has considerably increased and we can relate to them by sharing stories: stories about who they once were, before the dementia. Looking through a personhood lens, we re-member them: as the embodiment of a rich life story and as citizens of our community. A person with dementia, however, apart ...
Biochemical markers for improved diagnostic discrimination of Alzheimer's disease from dementia with Lewy bodies. University of Antwerp
Unraveling how VPS13C deficiency affects interorganellar lipid transport and lysosomal homeostasis and how this contributes to the neuropathogenesis of Dementia with Lewy Bodies KU Leuven
Dementia is the progressive loss of cognitive function that affects >50 million people worldwide. Dementia with Lewy bodies (DLB) is, after Alzheimer’s disease (AD), the second most prevalent cause of neurodegenerative dementia. Thus far, no causal genes have been identified making the exploration of underlying disease causing mechanisms very difficult, if not impossible. Whole genome sequencing recently identified compound heterozygous ...